EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections

Ryan K Shields, David L Paterson, Pranita D Tamma

Clinical Infectious Diseases · 01.05.2023 · 76 (Supplement_2) · S179-S193

DOI: 10.1093/cid/ciad094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 01.05.2023. Verfasst von Ryan K Shields und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRAB) is one of the top-priority pathogens for new antibiotic development. Unlike other antibiotic-resistant threats, none of the available therapies have been shown to consistently reduce mortality or improve patient outcomes in clinical trials. Antibiotic combination therapy is routinely used in clinical practice; however, the preferred combination has not been defined. This narrative review focuses on evidence-based solutions for the treatment of invasive CRAB infections. We dissect the promise and perils of traditional agents used in combination, such as colistin, sulbactam, and the tetracyclines, and offer clinical pearls based on our interpretation of the available data. Next, we investigate the merits of newly developed β-lactam agents like cefiderocol and sulbactam-durlobactam, which have demonstrated contrasting results in recent randomized clinical trials. The review concludes with the authors’ perspective on the evolving treatment landscape for CRAB infections, which is complicated by limited clinical data, imperfect treatment options, and a need for future clinical trials. We propose that effective treatment for CRAB infections requires a personalized approach that incorporates host factors, the site of infection, pharmacokinetic-pharmacodynamic principles, local molecular epidemiology of CRAB isolates, and careful interpretation of antibiotic susceptibility testing results. In most clinical scenarios, a dose-optimized, sulbactam-based regimen is recommended with the addition of at least one other in vitro active agent. Should sulbactam-durlobactam receive regulatory approval, recommendations will need to be re-evaluated with the most recent evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsHumansSulbactamCarbapenemsAnti-Bacterial AgentsColistinMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Acinetobactercefiderocolcolistindurlobactamsulbactam

Substanzen

SulbactamCarbapenemsAnti-Bacterial AgentsColistin

Autor:innen und Institutionen

  • Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Zitieren

APA

Shields, R. K., Paterson, D. L., & Tamma, P. D. (2023). Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections. Clinical Infectious Diseases, 76(Supplement_2), S179-S193. https://doi.org/10.1093/cid/ciad094

Vancouver

Shields RK, Paterson DL, Tamma PD. Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections. Clinical Infectious Diseases. 2023;76(Supplement_2):S179-S193. doi:10.1093/cid/ciad094

BibTeX
@article{Shields2023,
  author = {Shields, Ryan K and Paterson, David L and Tamma, Pranita D},
  title = {Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {Supplement_2},
  pages = {S179--S193},
  doi = {10.1093/cid/ciad094}
}
Kostenlos starten →